Literature DB >> 1658191

Block of L-type calcium channels by charged dihydropyridines. Sensitivity to side of application and calcium.

R S Kass1, J P Arena, S Chin.   

Abstract

We have studied block of L-type calcium channels by intracellular and extracellular application of the ionized dihydropyridine derivatives amlodipine and SDZ 207-180. We find that extracellular application of either drug causes voltage-dependent block of calcium channels. However, neither drug is effective when applied intracellularly. The insensitivity of calcium channels to intracellular drug is not due to the low concentrations of cytosolic calcium, because voltage-dependent block by ionized amlodipine, SDZ 207-180, and the neutral drug nisoldipine persists under conditions in which Ca0 is buffered by EGTA. In fact, the time course of the development of block by the ionized but not neutral drug molecules studied, is slower in the presence than in the absence of calcium. Our results indicate that the DHP binding site of the L-type calcium channel is close to the extracellular surface of the cell membrane and that ionized DHP molecules may interact with the receptor in a manner that is uniquely affected by calcium.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658191      PMCID: PMC2229044          DOI: 10.1085/jgp.98.1.63

Source DB:  PubMed          Journal:  J Gen Physiol        ISSN: 0022-1295            Impact factor:   4.086


  35 in total

1.  Potentiation of cardiodepressive action among calcium antagonists from different classes: evidence for a mechanism at the single calcium channel level.

Authors:  S Braun; N Frey; S Herzig; C Hilbert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

2.  Blockade of cardiac sodium channels. Competition between the permeant ion and antiarrhythmic drugs.

Authors:  M J Barber; D J Wendt; C F Starmer; A O Grant
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Extra- and intracellular action of quaternary devapamil on muscle L-type Ca(2+)-channels.

Authors:  S Berjukov; S Aczel; B Beyer; S D Kimball; M Dichtl; S Hering; J Striessnig
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

4.  The molecular mode of action of the Ca agonist (-) BAY K 8644 on the cardiac Ca channel.

Authors:  M Bechem; H Hoffmann
Journal:  Pflugers Arch       Date:  1993-08       Impact factor: 3.657

Review 5.  Molecular basis of drug interaction with L-type Ca2+ channels.

Authors:  J Mitterdorfer; M Grabner; R L Kraus; S Hering; H Prinz; H Glossmann; J Striessnig
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

6.  Binding constants determined from Ca2+ current responses to rapid applications and washouts of nifedipine in frog cardiac myocytes.

Authors:  P F Méry; L Hove-Madsen; J L Mazet; R Hanf; R Fischmeister
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

7.  Modulation of calcium channels in arterial smooth muscle cells by dihydropyridine enantiomers.

Authors:  S Hering; A D Hughes; E N Timin; T B Bolton
Journal:  J Gen Physiol       Date:  1993-03       Impact factor: 4.086

8.  Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels.

Authors:  C Strübing; S Hering; H Glossmann
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

9.  Enhancement of Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by phorbol esters with and without activation of protein kinase C.

Authors:  H L Reeve; P F Vaughan; C Peers
Journal:  Pflugers Arch       Date:  1995-03       Impact factor: 3.657

10.  Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.

Authors:  S Salomone; T Godfraind
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.